ABSCIENCES (EPA:AB) AB Science announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib
Transparency directive : regulatory news
19/08/2021 17:51